Trade Valneva SE - VLA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02141% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000812% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | France | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.23 |
| Open | 3.22 |
| 1-Year Change | -52.23% |
| Day's Range | 3.18 - 3.25 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 3.23 | 0.15 | 4.87% | 3.08 | 3.27 | 3.08 |
| Jul 24, 2024 | 3.24 | 0.00 | 0.00% | 3.24 | 3.29 | 3.20 |
| Jul 23, 2024 | 3.30 | -0.14 | -4.07% | 3.44 | 3.45 | 3.29 |
| Jul 22, 2024 | 3.41 | 0.05 | 1.49% | 3.36 | 3.47 | 3.26 |
| Jul 19, 2024 | 3.27 | -0.14 | -4.11% | 3.41 | 3.43 | 3.25 |
| Jul 18, 2024 | 3.45 | 0.01 | 0.29% | 3.44 | 3.49 | 3.41 |
| Jul 17, 2024 | 3.46 | 0.02 | 0.58% | 3.44 | 3.49 | 3.43 |
| Jul 16, 2024 | 3.46 | 0.11 | 3.28% | 3.35 | 3.50 | 3.30 |
| Jul 15, 2024 | 3.32 | -0.05 | -1.48% | 3.37 | 3.43 | 3.30 |
| Jul 12, 2024 | 3.39 | 0.07 | 2.11% | 3.32 | 3.48 | 3.32 |
| Jul 11, 2024 | 3.33 | 0.00 | 0.00% | 3.33 | 3.35 | 3.28 |
| Jul 10, 2024 | 3.33 | 0.09 | 2.78% | 3.24 | 3.33 | 3.24 |
| Jul 9, 2024 | 3.28 | 0.12 | 3.80% | 3.16 | 3.36 | 3.16 |
| Jul 8, 2024 | 3.16 | 0.02 | 0.64% | 3.14 | 3.25 | 3.13 |
| Jul 5, 2024 | 3.17 | -0.01 | -0.31% | 3.18 | 3.24 | 3.13 |
| Jul 4, 2024 | 3.17 | -0.03 | -0.94% | 3.20 | 3.25 | 3.16 |
| Jul 3, 2024 | 3.22 | -0.04 | -1.23% | 3.26 | 3.28 | 3.17 |
| Jul 2, 2024 | 3.28 | 0.11 | 3.47% | 3.17 | 3.35 | 3.04 |
| Jul 1, 2024 | 3.25 | -0.11 | -3.27% | 3.36 | 3.41 | 3.24 |
| Jun 28, 2024 | 3.11 | -0.09 | -2.81% | 3.20 | 3.26 | 3.07 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Valneva SE Company profile
About Valneva SE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Financial summary
BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.
Equity composition
07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).
| Industry: | Biotechnology & Medical Research (NEC) |
6 rue Alain Bombard
SAINT-HERBLAIN
PAYS DE LA LOIRE 44800
FR
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com